Wall Street’s Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

by | Nov 14, 2025 | News

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga’s extensive database of analyst ratings, including by analyst accuracy.

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.

Pfizer Inc (NYSE:PFE)

  • Dividend Yield: 6.67%
  • Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price target from $33 to $32 on Oct. 10, 2025. This analyst has an accuracy rate of 67%.
  • B of A Securities analyst Tim Anderson maintained a Neutral rating and raised the price target from $28 to $30 on Oct. 3, 2025. This analyst has an accuracy rate of 66%.
  • Recent News: On Nov. 13, Pfizer announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ:MTSR).
  • Benzinga Pro’s real-time newsfeed alerted to latest PFE news.

DENTSPLY SIRONA Inc (NASDAQ:XRAY)

  • Dividend Yield: 5.84%
  • William Blair analyst Brandon Vazquez downgraded the stock from Outperform to Market Perform on Nov. 7, 2025. This analyst has an accuracy rate of 68%.
  • UBS analyst Kevin Caliendo maintained a Buy rating and slashed the price target from $24 to $23 on Oct. 28, 2025. This analyst has an accuracy rate of 67%
  • Recent News: On Nov. 6, Dentsply Sirona posted weaker-than-expected third-quarter earnings and lowered guidance.
  • Benzinga Pro’s real-time newsfeed alerted to latest XRAY news

Viatris Inc (NASDAQ:VTRS)

  • Dividend Yield: 4.40%
  • Goldman Sachs analyst Matt Dellatorre initiated coverage on the stock with a Neutral rating and a price target of $10 on June 6, 2025. This analyst has an accuracy rate of 68%.
  • Piper Sandler analyst David Amsellem reiterated a Neutral rating and slashed the price target from $14 to $10 on March 5, 2025. This analyst has an accuracy rate of 78%.
  • Recent News: On Nov. 6, Viatris posted better-than-expected quarterly earnings.
  • Benzinga Pro’s real-time newsfeed alerted to latest VTRS news

Read More:

Photo via Shutterstock